A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...
This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...
Zacks Investment Research on MSN
TMO stock set to gain from the expansion of Gibco Bacto portfolio
Thermo Fisher Scientific TMO recently announced the expansion of its Gibco Bacto CD portfolio. The Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X) are two next-generation ...
Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...
As we close out 2025, I am excited to reflect on a year marked by significant clinical progress, robust data validation, and strategic execution that has significantly strengthened IMUNON's position.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidenceWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world ...
This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...
A research team shows that environmentally relevant antibiotic levels can greatly accelerate the spread of antibiotic resistance genes.A research ...
Researchers in China developed a 'one-pot' Cas12i3/Cas13d-based assay, designated OBServe.v2, to discriminate between ASFV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback